Johnson & Johnson
JNJ
|
News
|
$148.22
-0.9%
3.3M
|
Health Technology
(0.0% 1d) (-3.8% 1m) (-9.4% 1y) (0.0% 2d) (0.9% 3d) (3.2% 7d) (NaN% volume)
Earnings Calendar: 2024-01-23
Market Cap: $ 357,178,044,264
http://www.jnj.com
Sec Filling | Patents | 132200 employees
(US) Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
vaccine cardiovascular eye infectious disease diabetes diabetic hypertension urea pulmonary hypertension women health immunology metabolic women
add to watch list Paper trade email alert is off
Press-releases
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published: 2024-04-24 (Crawled : 08:00) - globenewswire.com
ALVO | $13.65 1.87% 120K
|
n/a
|
| O: 2.16%
H: 0.0%
C: 0.0%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
avt05 simponi biosimilar for topline results study
Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
Published: 2024-04-24 (Crawled : 07:00) - prnewswire.com
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
precision company million series therapeutics
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
RLYB | News | $1.645 -5.46% 150K
|
|
| O: -5.26%
H: 0.0%
C: 0.0%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7208 -3.3% 770K
|
Health Technology
|
| O: -4.49%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.24 -0.67% 180K
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
NKTR | News | $1.405 -1.06% 290K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
MOR | News | $18.06 0.11% 96K
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
AMRN | News | $0.8685 -1.68% 290K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
GOOGL | News S | $157.55 -0.45% 9.6M
|
Technology Services
|
| O: 0.27%
H: 0.0%
C: 0.0%
GOOG | News 4 | $159.33 -0.37% 8.2M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
OCX | News | $2.38 -3.06% 24K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
biopharma
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Published: 2024-04-24 (Crawled : 08:00) - biospace.com/
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
drug for therapeutics development
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
RLYB | News | $1.645 -5.46% 150K
|
|
| O: -5.26%
H: 0.0%
C: 0.0%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7208 -3.3% 770K
|
Health Technology
|
| O: -4.49%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.24 -0.67% 180K
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
NKTR | News | $1.405 -1.06% 290K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
MOR | News | $18.06 0.11% 96K
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
AMRN | News | $0.8685 -1.68% 290K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
GOOGL | News S | $157.55 -0.45% 9.6M
|
Technology Services
|
| O: 0.27%
H: 0.0%
C: 0.0%
GOOG | News 4 | $159.33 -0.37% 8.2M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
OCX | News | $2.38 -3.06% 24K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
biopharma
BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
antibody collaboration design
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC | $2.43 -6.54% 590K
|
Health Technology
|
| O: -5.77%
H: 0.0%
C: 0.0%
business
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
ABT | News | $106.96 -0.59% 2.6M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
PRGO | $30.47 -0.07% 280K
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
first ceo revenue medical
Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments
Published: 2024-04-23 (Crawled : 11:00) - prnewswire.com
VEEV | $200.36 -0.37% 190K
|
Technology Services
|
| O: 1.02%
H: 2.26%
C: 0.12%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
brands reach biopharma prime
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 55% | 45% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Last 48 Hours Insiders Buying
NWFL | News | $24.0 -0.46% 4.6K
|
Finance
|
17:00
MNSB P 310 | $15.91 -2.75% 18K
|
Finance
|
15:30
TPL P 3 | $585.605 -0.38% 11K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 3.1K
|
Finance and Insurance
|
15:01
MEGI | $11.98 74K
|
|
00:30
CTRN P 29000 | $21.855 -1.69% 26K
|
Retail Trade
|
22:00
CONN | $3.735 0.95% 21K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.685 6.6K
|
Utilities
|
18:30
CMTV P 700 | $16.59 1K
|
Finance and Insurance
|
18:30
FNB | $13.56 -0.51% 420K
|
Finance
|
17:30
RMCF | $3.54 2.5K
|
Consumer Non-Durables
|
20:10